DENVER, CO, Nov. 5 /PRNewswire-FirstCall/ - Medical InternationalTechnology Inc. (MDLH. PK) (http://www.mitcanada.ca http://www.mitinvest.ca),is pleased to announce that it has received a Non-Refundable deposit of 1.3Million Dollars for the worldwide rights to market and sell all of MedicalInternational Technology Inc.'s present and future Needle-Free Jet-Injectorsfor the human and animal markets. This deposit is part of an agreement undernegotiation, which will be disclosed when finalized.
Over the past 12 months, "MIT" has consolidated its efforts, hassignificantly strengthened its team and has reorganized its marketing/salesdepartments and financial bases in anticipation of its future growth. Theresults achieved will be reflected during the 2007 / 2008 fiscal year.
Medical International Technology Inc. is in negotiations with majorworldwide distributors and possible Joint-Venture partners in differentcountries around the world for its present and future Jet Injector products inthe human and animal fields.
Medical International Technology Inc. is pleased to continue providing asafe and effective means to help prevent the spread of deadly diseases to bothhumans and animals through the use of the MED-JET(R) and AGRO-JET(R)needle-free injection systems.
Medical International Technology Inc. also announces its filling of theSeptember 30, 2006 fiscal year-end 10K.
MIT CANADA, with offices in Montreal, is a subsidiary of Denver,Colorado-based Medical International Technology, Inc. (MIT USA), whichspecializes in the development, production, marketing and sale of needle-freeinjectors both for humans and animals, for individual and mass vaccinations.
The statements which are not historical facts contained in this pressrelease are forward-looking statements that involve certain risks anduncertainties, including but not limited to risks associated with theuncertainty of future financial results, additional financing requirements,development and acquisition of new product lines and services, governmentapproval processes, the impact of competitive products or pricing atechnological changes, the effect of economic conditions and otheruncertainties, and the risk factors set forth from time to time in theCompany's SEC reports, including but not limited to its annual report on Form10-KSB; its quarterly reports on Forms 10-QSB; and any reports on Form 8-K.Medical International Technology Inc. takes no obligation to update or correctforward-looking statements.Karim Menassa, President On Behalf of the Board of Directors About Medical International Technology, Inc.
SOURCE MEDICAL INTERNATIONAL TECHNOLOGIES INC.